Abstract
Of all malignancies diagnosed in men between 17 and 45 years of age, 60% are germ cell tumors (GCT). GCT arise from carcinoma in situ cells, which are thought to originate from a transformed fetal germ cell, the gonocyte. Seminoma together with embryonal carcinoma represent the most frequent subtypes of GCT. However, the nature of the molecular pathways involved in seminoma formation remains elusive. Therefore, analysis of appropriate cell culture systems is an important prerequisite for further understanding of the etiology of this tumor entity. Although several cell lines for embryonal carcinoma have been established and analyzed, so far only two cell lines from seminoma patients have been reported. In the present study, we have analyzed these seminoma cell lines (TCam-2 and JKT-1) and compared the gene-expression profiles with those of normal tissue and of seminoma and embryonal carcinoma by using DNA Array technology. We have found that TCam-2 clusters with the group of classical seminoma, whereas JKT-1 clusters with the group of embryonal carcinoma. Using reverse transcription/polymerase chain reaction, Western blot, and immunohistochemistry, we have confirmed the seminoma-like nature of TCam-2, whereas JKT-1 lacks expression for most of the genes detectable in GCTs, thus making doubtful the germ cell nature of this cell line. The data represent the first genome-wide expression analysis of the two cell lines and comparison/clustering with subgroups of germ cell tumors. Only TCam-2 seems to represent a suitable in vitro model for seminoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adami HO, Bergstrom R, Mohner M, Zatoński W, Storm H, Ekbom A et al (1994) Testicular cancer in nine northern European countries. Int J Cancer 59:33–38
Almstrup K, Ottesen AM, Sonne SB, Hoei-Hansen CE, Leffers H, Rajpert-De Meyts E et al (2005a) Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ. Cell Tissue Res 322:159–165
Almstrup K, Hoei-Hansen CE, Nielsen JE, Wirkner U, Ansorge W, Skakkebaek NE et al (2005b) Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. Br J Cancer 92:1934–1941
Biermann K, Heukamp LC, Steger K, Zhou H, Franke FE et al (2007) Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors. Cancer Genomics Proteomics (in press)
Ezeh UI, Turek PJ, Reijo RA, Clark AT (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104:2255–2265
Franke FE, Pauls K, Kerkman L, Steger K, Klonisch T, Metzger R et al (2000) Somatic isoform of angiotensin I-converting enzyme in the pathology of testicular germ cell tumors. Hum Pathol 31:1466–1476
Goddard NC, McIntyre A, Summersgill B, Gilbert D, Kitazawa S, Shipley J (2007) KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature. Int J Androl 30:337–349
Hatakeyama S, Ohyama C, Minagawa S, Inoue T, Kakinuma H, Kyan A et al (2004) Functional correlation of trophinin expression with the malignancy of testicular germ cell tumor. Cancer Res 64:4257–4262
Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek E et al (2004) Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res 10:8521–8530
Jager R, Werling U, Rimpf S, Jacob A, Schorle H (2003) Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model. Mol Cancer Res 1:921–929
Jo Y, Kinugawa K, Matsuki T, Morioka M, Tanaka H (1999) Analysis of the biological properties and use of comparative genomic hybridization to locate chromosomal aberrations in the human testicular seminoma cell line JKT-1 and its highly metastatic cell line JKT-HM. BJU Int 83:469–475
Jong J de, Stoop H, Gillis AJ, Gurp RJ van, Drunen E van, Beverloo HB et al (2007) JKT-1 is not a human seminoma cell line. Int J Androl 30:350–365
Kinugawa K, Hyodo F, Matsuki T, Jo Y, Furukawa Y, Ueki A et al (1998) Establishment and characterization of a new human testicular seminoma cell line, JKT-1. Int J Urol 5:282–287
Kitazawa S, Takenaka A, Kondo T, Mizoguchi A, Kitazawa R (2006) Protruding disordered loop of gC1qR is specifically exposed and related to antiapoptotic property in germ cell lineage. Histochem Cell Biol 126:665–677
Kobayashi T, Fujii T, Jo Y, Kinugawa K, Fujisawa M (2004) Possible mechanism responsible for the acquisition of resistance to cis-diamminedichloroplatinum (II) by cultured human testicular seminoma cells. J Urol 171:1929–1933
Korkola JE, Houldsworth J, Dobrzynski D, Olshen AB, Reuter VE, Bosl GJ et al (2005) Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene 24:5101–5107
Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE et al (2006) Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 66:820–827
Koshida K, Konaka H, Kato H, Miyagi T, Egawa M, Uchibayashi T et al (2000) [Correlation between expression of metastasis-related genes and lymph node metastasis in testicular cancer]. Hinyokika Kiyo 46:775–781
Lifschitz-Mercer B, Elliott DJ, Issakov J, Leider-Trejo L, Schreiber L, Misonzhnik F et al (2002) Localization of a specific germ cell marker, DAZL1, in testicular germ cell neoplasias. Virchows Arch 440:387–391
Looijenga LH, Oosterhuis JW (2002) Pathobiology of testicular germ cell tumors: views and news. Anal Quant Cytol Histol 24:263–279
Mizuno Y, Gotoh A, Kamidono S, Kitazawa S (1993) [Establishment and characterization of a new human testicular germ cell tumor cell line (TCam-2)]. Nippon Hinyokika Gakkai Zasshi 84:1211–1218
Muller-Tidow C, Diederichs S, Schrader MG, Vogt U, Miller K, Berdel WF et al (2003) Cyclin A1 is highly expressed in aggressive testicular germ cell tumors. Cancer Lett 190:89–95
Okada K, Katagiri T, Tsunoda T, Mizutani Y, Suzuki Y, Kamada M et al (2003) Analysis of gene-expression profiles in testicular seminomas using a genome-wide cDNA microarray. Int J Oncol 23:1615–1635
Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210–222
Pauls K, Jager R, Weber S, Wardelmann E, Koch A, Büttner R et al (2005) Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors. Int J Cancer 115:470–477
Peitz M, Jager R, Patsch C, Jager A, Egert A, Schorle H et al (2007) Enhanced purification of cell-permeant Cre and germline transmission after transduction into mouse embryonic stem cells. Genesis 45:508–517
Rajpert-De Meyts E, Jacobsen GK, Bartkova J, Aubry F, Samson M, Bartek J et al (2003) The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma. Histopathology 42:217–226
Roger C, Mograbi B, Chevallier D, Michiels JF, Tanaka H, Segretain D et al (2004) Disrupted traffic of connexin 43 in human testicular seminoma cells: overexpression of Cx43 induces membrane location and cell proliferation decrease. J Pathol 202:241–246
Roger C, Lambard S, Bouskine A, Mograbi B, Chevallier D, Nebout M et al (2005) Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor beta and aromatase. J Mol Endocrinol 35:191–199
Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mitzutani Y et al (2005) Differential response at the hGABP/E4TF1 site of retinoblastoma gene promoter in human testicular seminoma cells. Oncol Rep 13):871–874
Skakkebaek NE (1972) Possible carcinoma-in-situ of the testis. Lancet II:516–517
Skakkebaek NE (1978) Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 2:157–170
Skotheim RI, Monni O, Mousses S, Fossa SD, Kallioniemi OP, Lothe RA et al (2002) New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res 62:2359–2364
Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD et al (2005) Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 65:5588–5598
Sugimura J, Foster RS, Cummings OW, Kort EJ, Takahashi M, Lavery TT et al (2004) Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis. Clin Cancer Res 10:2368–2378
Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116–5121
Acknowledgements
We thank Dr. Janet Shipley (Institute of Cancer Research, Sutton, England) for the TCam-2 cells, Dr. Michiko Fukuda (The Burnham Institute, La Jolla, Calif.) for the JKT-1 cells, and Dr. F. Honecker (Hamburg University Medical Center, Department of Oncology/Hematology, Hamburg, Germany) for the EC cell line 2102EP. The skilful technical assistance of Susanne Steiner and of Volker Böhnert during his “MBM Wahlmodul” is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
D. Eckert, D. Nettersheim, and L. C. Heukamp contributed equally to this work. This study was supported by DFG grants 503-6 and 503-7 to H.S.
Electronic supplementary material
Below are the links to the electronic supplementary material.
Supplemental Data S1
(GIF 264 kb)
Supplemental Data S2
(DOC 48 kb)
Supplemental Data S3
(HTM 48 kb)
Rights and permissions
About this article
Cite this article
Eckert, D., Nettersheim, D., Heukamp, L.C. et al. TCam-2 but not JKT-1 cells resemble seminoma in cell culture. Cell Tissue Res 331, 529–538 (2008). https://doi.org/10.1007/s00441-007-0527-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-007-0527-y